Serif Health has secured a significant minority investment from SEVA Growth LP to scale its AI-powered healthcare price transparency data and intelligence for providers, payers, employers, and third-party administrators.
Earlier this year, Serif Health launched Signal Ask, a deployment-ready enterprise AI application that allows users to query pricing data in plain language, without needing to know billing codes, data structures, or which dataset to search.
Signal Ask cleans, validates, and standardizes the information provided by hundreds of payers, thousands of hospitals, and billions of rate records for its clients on its platform.
Launched in 2020, Serif Health has onboarded more than 250 organizations that have relied on the data provided by Serif to benchmark, evaluate networks, and understand market dynamics with the most up-to-date healthcare pricing information in a format that they can actually use.
Based in Brooklyn, NY, SEVA Growth LP is a growth equity firm exclusively focused on helping customer-centric founders building technology-enabled services companies. The equity firm has backed many customer-centric startups to date. Its notable latest investments include Chicory Inc, Teleskope Technologies Inc., TitanFile Inc, and Pronto Inc.
Serif said the proceeds from the transaction will fund its sales and growth initiatives for its pipeline of new product functionality and data APIs.
According to our latest funding insights, digital health startups have secured more than $20 billion in VC funding so far this year.
More recently, InsideDesk, a leading provider of AI-powered revenue cycle management (RCM) solutions for dental service organizations (DSOs), raised $12.6 million in funding led by Pender Ventures, with participation from existing investors Round13 Capital and Graphite Ventures.
Candid Health, a leading provider of a revenue cycle management platform for healthcare providers, raised a $120 million Series D round, bringing its total funding to date to approximately $220 million, Fortune reported exclusively.